Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 41,667 |
|
|||||
| News | - | ||||||
| Day High | 2.29 | Low High |
|||||
| Day Low | 2.01 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| BriaCell Therapeutics Corporation | BCTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0276 | -1.29% | 2.12 | 16:48:08 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.16 | 2.01 | 2.29 | 2.02 | 2.1476 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 239 | 41,667 | $ 2.14 | $ 89,060 | - | 2.01 - 7.59 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:40:39 | formt | 200 | $ 2.12 | USD |
BriaCell Therapeutics Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 169.41M | 15.98M | - | 0 | -20.3M | -1.27 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
BriaCell Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BCTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.71 | 2.8499 | 2.01 | 2.35 | 65,101 | -0.59 | -21.77% |
| 1 Month | 2.35 | 3.03 | 2.01 | 2.65 | 75,908 | -0.23 | -9.79% |
| 3 Months | 3.96 | 4.37 | 2.01 | 3.10 | 87,438 | -1.84 | -46.46% |
| 6 Months | 5.56 | 5.97 | 2.01 | 3.98 | 100,590 | -3.44 | -61.87% |
| 1 Year | 7.33 | 7.59 | 2.01 | 5.22 | 99,741 | -5.21 | -71.08% |
| 3 Years | 3.27 | 12.47 | 2.01 | 6.83 | 869,251 | -1.15 | -35.17% |
| 5 Years | 4.24 | 12.47 | 2.01 | 6.62 | 894,939 | -2.12 | -50.00% |
BriaCell Therapeutics Description
| BriaCell Therapeutics Corp is an immuno-oncology focused biotechnology company developing targeted and safe approaches for the management of cancer. BriaCell, in collaboration with Incyte Corp., is conducting a Phase I/IIa clinical trial of Bria-IMT, its lead candidate, in a Combination Study with Incyte drugs, INCMGA00012, and epacadostat, in advanced breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for advanced breast cancer. Bria-OTS immunotherapy treatments are personalized to match the patient without the need for personalized manufacturing and is designed to produce a potent and selective immune response against the cancer of each patient eliminating the time, expense and complex manufacturing logistics associated with immunotherapies. |
